Prognostic Significance of C-Reactive Protein or Prealbumin in Pancreatic Ductal Adenocarcinoma
Journal of Surgical Research · 2025-02 · 306 · 543-553
DOI: 10.1016/j.jss.2024.12.047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Research, 2025-02. Verfasst von Yu Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Cl…. Hauptthemen laut MEDLINE: C-Reactive Protein, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Prealbumin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: To clarify the prognostic significance of the C-reactive protein to prealbumin ratio (CRP or PALB) in patients with pancreatic cancer after radical resection. METHODS: A total of 432 patients with pathologically confirmed pancreatic ductal adenocarcinoma were enrolled in this retrospective study. The predictive capacity of various inflammatory indices was analyzed and compared using the area under the time-dependent receiver operating characteristic curve, including CRP or PALB, CRP-to-albumin ratio, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio. The univariate and multivariate Cox hazard models were employed to analyze the effects of CRP or PALB on overall survival (OS) and recurrence-free survival (RFS). RESULTS: The optimal cut-off value for preoperative CRP or PALB was 5.94, which was derived from the receiver operating characteristic curve. In comparison with traditional inflammatory indices, CRP or PALB had the highest area under the time-dependent receiver operating characteristic curve (0.693 for 3-y OS, 0.664 for 3-y RFS, 0.662 for 5-y OS, and 0.670 for 5-y RFS), all with P 5.94) exhibited significantly poorer OS and RFS (median OS: 20.0 versus. 38.0 mo, P = 0.003; median RFS: 10.0 versus. 22.0 mo, P < 0.001) than those in the low CRP or PALB group (CRP or PALB ≤5.94). The multivariate analysis indicated that the HCP was independently associated with poor OS (hazard ratio (HR): 1.556, 95% confidence interval (CI) [1.089-2.222], P = 0.015) and RFS (HR: 1.551, 95% CI [1.135-2.119], P = 0.006). CONCLUSIONS: The predictive capacity of preoperative CRP or PALB in pancreatic ductal adenocarcinoma patients exceeds that of traditional inflammatory indices. HCP levels are significantly correlated with a poor prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, PR China.
- Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, PR China; Department of He…
- Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, PR China. Electronic addre…
Zitieren
APA
Guo, Y., Dou, Y., Ma, X., Li, Z., Li, H., Sun, X., Gao, C., Liang, Y., & Zhao, T. (2025). Prognostic Significance of C-Reactive Protein or Prealbumin in Pancreatic Ductal Adenocarcinoma. Journal of Surgical Research, 306, 543-553. https://doi.org/10.1016/j.jss.2024.12.047
Vancouver
Guo Y, Dou Y, Ma X, Li Z, Li H, Sun X, et al. Prognostic Significance of C-Reactive Protein or Prealbumin in Pancreatic Ductal Adenocarcinoma. Journal of Surgical Research. 2025;306:543-553. doi:10.1016/j.jss.2024.12.047
BibTeX
@article{Guo2025,
author = {Guo, Yu and Dou, Yibo and Ma, Xi and Li, Zhifei and Li, Haorui and Sun, Xugang and Gao, Chuntao and Liang, Yuexiang and Zhao, Tiansuo},
title = {Prognostic Significance of C-Reactive Protein or Prealbumin in Pancreatic Ductal Adenocarcinoma},
journal = {Journal of Surgical Research},
year = {2025},
volume = {306},
pages = {543--553},
doi = {10.1016/j.jss.2024.12.047}
}
EUVIMED